Summary The interactions of radiation and adriamycin (ADM), bleomycin (BLM), mitomycin C (MM-C), or cis-diamminedichloroplatinum II (cis-DDP) in mouse jejunal crypt cells were studied using the microcolony survival assay. ADM administered from 24 h before to 48 h after irradiation resulted in an almost constant enhancement of the radiation response, the dose effect factor (DEF) being 1.19. The effect of BLM was extremely dependent on the sequence and interval between drug administration and irradiation. The most pronounced effect was observed when BLM was given 2 h before irradiation (DEF = 2.40), at which interval the Do surprisingly increased by a factor of 1.4. Administration of MM-C from 24 h before to 24 h after irradiation enhanced the radiation response. The effect peaked on administration 6 h before irradiation (DEF = 1.21) and diminished by application after irradiation. Cis-DDP enhanced the radiation response only when given before irradiation resulting in a DEF of 1.23 and a decreased Do,
The more frequent recourse to combined drugradiation regimens in cancer therapy has unfortunately increased the frequency of unexpected and unacceptable normal tissue reactions (Muggia et al., 1978; Peckham & Collis, 1981; Phillips, 1980; Phillips & Fu, 1976) . This may be attributed to our still limited understanding of the interactions of radiation and cancer chemotherapeutic agents which in turn provides the rationale for the conduct of more experimental studies of this subject. Attention should especially focus on drug-radiation interactions in critical normal tissues and the dependence on the intervals and sequence of the two treatment modalities.
The intestinal tract mucosa is a critical normal tissue in which acute radiation effects can be studied by use of the microcolony survival assay (Withers & Elkind, 1970) . However, the study of the combined effects of irradiation and cancer chemotherapeutic drugs requires a modification of the assay by varying the assay time according to the effect of the drug on the regeneration time of the surviving intestinal crypts (von der Maase & Overgaard, 1983) . Thus, the interactions of radiation and cyclophosphamide, 5-fluorouracil and methotrexate have previously been investigated (von der Maase, 1984a) . The present study continues along this line and its purpose was to evaluate the effect on mouse jejunal crypt cells of adriamycin, bleomycin, mitomycin C and cis-diamminedichloroplatinum II administered before, simultaneously with and after irradiation.
Materials and methods
Unanaesthetized male C3D2F,/Bom mice (C3H/Tify x DBA/2,S), 9-12 weeks of age, with good access to air were exposed to single-dose whole-body irradiation with a 250 kV Muller X-ray unit as previously described (von der Maase, 1984a) .
Mitomycin C (MM-C) and cis-diamminedichloroplatinum II (cis-DDP) were kindly provided by Bristol-Myers A/S, adriamycin (ADM) by Farmitalia, Carlo Erba, and bleomycin (BLM) by H. Lundbeck and Co. A/S. Each drug was applied at the maximum tolerated dose (MTD), equivalent to the dose that would kill -1% of the mice within 60 days. The MTDs were estimated as previously described (von der Maase, 1984a) . BLM was dissolved in isotonic saline and the other drugs in sterile distilled water. All drugs were administered intraperitoneally as single doses at a constant volume of 0.02 ml g1 body wt.
Crypt survival
The crypt number was scored in 2 jejunal crosssections per mouse, and all survival curves were based on 6 mice per dose point (von der Maase & Overgaard, 1983) . Crypt cell survival was determined according to the method of Withers & Elkind (1970) . In the interval studies the end point was the number of crypts per circumference without calculation of the number of crypt cells. All points in the interval studies and all survival curves were reproduced at least once.
The assay times were based on the estimated regeneration times for each drug-radiation combination (von der Maase & Overgaard, 1983 Figure 2 . ADM did not change the Do whereas the SCIOGY was significantly decreased compared with the SC10GY after radiation alone (P<0.001). The DEF and IER were 1.19 and 5.5, respectively (see Table I ).
BLM and irradiation BLM was given from 14 days before to 72 h after 7 Gy. As seen in Figure 3 , its influence on the radiation effect was extremely dependent on the intervals and sequence of the combined treatment.
Administration of the drug 1-6 h before irradiation had the most pronounced effect which gradually diminished when the interval was prolonged. In contrast, administration of BLM after irradiation enhanced the radiation effect to a much smaller extent. The curve describing the effect of BLM after irradiation experienced a sharp drop at 12 h and the effect disappeared at 48 h. BLM administered 15min before irradiation statistically significantly displaced the survival curve to the left (P<0.001) without changing the Do (Figure 2 ). The curve was displaced further to the left when BLM was given 2h before irradiation (Figure 2 ), which compared with the 15min interval increased the DEF values from 1.70 to 2.40 and the IER values from 95 to 139. At the 2 h interval the Do was increased by a factor of 1.4 (see Table I ). The difference in the Do values was statistically significant (P<0.001).
MM-C and irradiation MM-C was administered from 72h before to 72h after 9Gy (Figure 4 ). The radiation response was enhanced at administration from 24h before to 24h after irradiation. The effect diminished at administration after irradiation and indicated a more pronounced effect on administration 6 h before irradiation. This possibly more pronounced effect was tested by establishment of survival curves for MM-C given 15min and 6h before irradiation. In both cases, the enhanced radiation effect, as expressed by the SCiOGY, was found to be statistically significant (P<0.001), and the effect of MM-C 6h before irradiation increased significantly compared with that of MM-C 15 min before irradiation (P <0.005). For neither drug-radiation interval did the Do change as compared to the Do for radiation alone. The data are given in Table I . Dose (Gy) Figure 2 Survival curves for mouse jejunal crypt cells after radiation alone, after ADM 15min before irradiation and after BLM either 15min or 2h before irradiation. Different symbols represent independent experiments. The curves are based on the pooled data from independent, not significantly different experiments. Each point is the mean value for 6 mice. Standard errors are indicated by bars except when enclosed by the experimental points. Survival curve characteristics are presented in Table I . Cis-DDP and irradiation As seen in Figure 5 , cis-DDP enhanced the radiation response only when given from 15 min to 6 h before irradiation and it had no effect if administered after irradiation. Comparison of the survival curve for drug administration 15 min before irradiation and the survival curve for radiation alone showed that cis-DDP statistically significantly displaced the curve to the left (P < 0.001) and decreased the Do (P < 0.005). The DEF and IER values were 1.23 and 8.4, respectively. Cis-DDP administration 1 h before irradiation revealed similar results with a statistically significantly decreased Do (P <0.05). All data are summarized in Table I . Discussion ADM combined with irradiation was found to increase the regeneration time to 102h compared to 90 h following radiation alone. The increased regeneration time is probably due to an ADMinduced delayed proliferation of the surviving cells which corresponds to the observations made by Burholt et al. (1975 Burholt et al. ( ,1977 . It has previously been discussed that the assay time must be adjusted to allow scoring of the crypt number at an equivalent crypt size (von der Maase, 1984a; von der Maase & Overgaard, 1983 ).
The present experiments were not specifically designed to elucidate the basic mechanisms of drugradiation interactions. Therefore, hypotheses of these mechanisms should be taken with great caution. It is especially emphasized that suggestions about interference with repair mechanisms can only be conjectural as split-dose experiments have not been carried out.
Administration of ADM from 24h before to 48h after irradiation caused an almost constantly increased cell kill, and the drug did not change the Do for radiation alone. These observations indicate that ADM and radiation may have an additive effect. Similar results have been obtained by others both using the crypt survival assay (Dethlefsen & Riley, 1979; Moore & Broadbent, 1980; , and the lethality assay (Dethlefsen & Riley, 1979; Schenken et al., 1976) .
BLM had the most pronounced effect when administered 2 h before irradiation, the DEF and IER values being 2.40 and 139, respectively. However, at this interval as opposed to the 15min interval, BLM surprisingly increased the Do for radiation alone by a factor of 1.4 (Figure 2 and Table I ). Although indicators of an extreme radiation-modifying effect, the DEF and IER values therefore underestimate the interactions of BLM and small radiation doses at this interval. If based on the surviving cells after 2 Gy instead of the SC10GY' the IER would be 1.2 x 103. As BLM also enhanced the radiation response, although to a lesser degree when given up to 24 h after irradiation (Figure 3 ), the combined effect was probably additive or at least partly additive. Although the number of crypts still was not restored 14 days after treatment with BLM alone, the radiation response was not enhanced at BLM administration 48 and 72h after irradiation (Figure 3) . The reason may be that the effect of BLM was not expressed when the crypt number was evaluated (90h after irradiation). As the effect of BLM was highly dependent on the intervals and sequence of the combined treatment (Figure 3) , mechanisms other than a simple additive one were obviously also present. The drop in the crypt number at drug administration 12 h after irradiation may indicate a synchronization effect and the extensive effect of BLM given 1-6h before irradiation may be caused by radiation inhibition of possible repair mechanisms of BLM-induced injury.
The increase in the Do at the 2 h interval cannot be accounted for with certainty although it may be explained by an "overkill" at the largest radiation doses in the combined treatment. A similarly increased Do was observed for MTX administered 1 h before irradiation (von der Maase, 1984a) and for large doses of ADM (15mg kg-') given immediately after irradiation (Moore & Broadbent, 1980 The pattern of the combined effects of MM-C and irradiation seen in Figure 4 may indicate that the two modalities act both in an additive way and by interference with repair mechanisms. The diminishing effect of MM-C when administered from a few hours before to 3 h after irradiation (Figure 4 ) may indicate a drug-induced decreased repair of sublethal radiation damage. The more pronounced effect on administration 6 h before irradiation may possibly be explained by radiation interference with repair of the effect of the drug. At present, there are no other data concerning the interactions of MM-C and irradiation in the intestinal tract epithelium. MM-C has also been shown to enhance the radiation induced skin reactions in mouse feet (von der Maase, 1984b). The fact that cis-DDP enhanced the radiation response only when given before irradiation and decreased the Do for radiation alone may indicate a true radiosensitization. This hypothesis has previously been suggested in both in vivo and in vitro studies (Douple & Richmond, 1978 and 1982 Overgaard & Khan, 1981;  Richmond & Powers, 1976; Richmond et al., 1977) . A selective enhancement at drug administration before irradiation was also found using the mouse foot skin scoring system (von der Maase, 1984b) . Other studies on the interactions of cis-DDP and irradiation in the intestinal mucosa have confirmed cis-DDP to have the most pronounced effect by administration before irradiation Luk et al., 1979; Schenken et al., 1979) . However, these studies also reported some degree of enhancement by administration after irradiation and suggested that the effect of cis-DDP was due to a reduced repair of radiation injury.
As for the previously investigated combinations of drugs and irradiation (von der Maase, 1984a), the present study illustrates the complexity and severity of drug-radiation interactions in the intestinal tract epithelium. These observations should serve to warn clinicians and should be taken into consideration in the planning of combined drug-radiation treatments of patients. On the basis of the crypt survival data it seems that short intervals between the two treatment modalities yield the most serious injuries which for some combinations were found to be dramatic. 
